WHRI Annual Research Review 2024 27 June 2024
On Wednesday 26 June we celebrated the achievements of our researchers at the WHRI Annual Research Review.
Queen Mary researchers awarded new funding for autoimmune disease drug development from the Connect Immune Research Initiative 17 June 2024
The Connect Immune Research initiative, is a charity partnership, which includes Versus Arthritis, JDRF, and the MS Society among its many partners. The initiative aims to understand how autoimmune diseases are linked and to explore how best to tackle multiple conditions simultaneously.
Professor Morris Brown honoured with 2024 Laureate Award from Endocrine Society 17 June 2024
Morris Brown, Professor of Endocrine Hypertension at Queen Mary University of London, has been named one of 14 leading endocrinologists to receive the prestigious 2024 Laureate Awards, the top honours in the field.
Professor Amrita Ahluwalia elected as Fellow of the Academy of Medical Sciences 21 May 2024
Amrita Ahluwalia, Professor of Vascular Pharmacology and Dean of Research for the Faculty of Medicine and Dentistry at Queen Mary University of London, is one of 58 exceptional biomedical and health scientists elected by the Academy to its prestigious Fellowship.
New cardiac research will save women’s lives by improving detection of heart failure 15 May 2024
An important new study involving researchers from Queen Mary University of London has advanced how heart failure is detected in women – meaning more female patients can be diagnosed at an earlier stage.
Research finds genetic variation that could lead to increased risk of viral infections 9 May 2024
A new study, led by Jesmond Dalli, Professor of Molecular Pharmacology at Queen Mary University of London, has found that people with a genetic mutation which leads to a reduction in a protein called LGR6, found on the surface of immune cells, have a decreased ability to clear viral infections.
Researchers identify over 2,000 genetic signals linked to blood pressure in study of over 1 million people 30 April 2024
The Queen Mary-led study reveals the most detailed picture yet of genetic contributors to blood pressure. The findings lead to improved polygenic risk scores, which will better predict blood pressure and risk for hypertension.
Celebrating International Day of Immunology: Q&A with Professor Sian Henson 29 April 2024
International Day of Immunology, observed annually on April 29, is dedicated to increasing global awareness of the importance of immunology for health and wellbeing. This year's theme is focused on the science of ageing and immunology.
To mark the day we spoke to Sian Henson, Professor in Immunology at the Centre for Translational Medicine and Therapeutics, William Harvey Research Institute, Queen Mary University of London.
Positive results from the KARDIA-2 Phase 2 study evaluating Zilebesiran for hypertension treatment have recently been announced 15 April 2024
The study showed significant reductions in blood pressure across three independent cohorts, with encouraging safety profiles. Zilebesiran aims to address treatment gaps in hypertension management and offers the potential for biannual dosing.
Researchers propose guidance for improving mental wellbeing among healthcare professionals 10 April 2024
Researchers at Queen Mary University of London have proposed a multi-pronged approach to support the mental wellbeing of healthcare professionals in the UK and globally.
Analysing the evidence: an interview with Professor Amrita Ahluwalia 10 April 2024
In this interview, Professor Ahluwalia discusses her role in analysing some of the evidence collected during a police investigation into the use of a legal chemical to assist suicide.
Secrets of the naked mole-rat: new study reveals how their unique metabolism protects them from heart attacks 27 March 2024
This unusual, subterranean mammal with extreme longevity shows genetic adaptations to low oxygen environments which could offer opportunities for advancing other areas of physiological and medical research in humans.
Success for WHRI at the FMD Staff Awards 2024 8 March 2024
The FMD Staff Awards, hosted by the Faculty of Medicine and Dentistry (FMD) at Queen Mary University of London, recently took place at the Barbican Conservatory. The event proved to be a huge success for the William Harvey Research Institute (WHRI), as staff secured an impressive total of five awards.
Professor Li Chan named winner of 2024 European Journal of Endocrinology Award by the European Society of Endocrinology 27 February 2024
The European Society of Endocrinology (ESE) announced that the 2024 European Journal of Endocrinology (EJE) Award has been awarded to Professor Li Chan.
Queen Mary part of innovative project using AI to create personalised therapies for heart patients 20 February 2024
The project will develop personalised treatment for heart patients, using their own genetic and other medical information.
New study explores the genetic links between thyroid function, borderline personality disorder and schizophrenia 16 February 2024
In a new study, published in Borderline Personality Disorder and Emotion Dysregulation, Springer Nature, researchers from Queen Mary University of London investigate the association between genetics, thyroid function, and mental health disorders.
New study shows personalised approach starting with small drug doses adjusted according to progress improved treatment of hypertension during COVID lockdown 8 February 2024
A new study published in the Journal of the American Heart Association shows that personalising the dose of amlodipine using novel doses can improve blood pressure (BP) control and achieve high adherence in participants measuring their BP at home.
Study finds new treatment to reverse inflammation and arterial blockages in rheumatoid arthritis 5 February 2024
Researchers from Queen Mary University of London have found that the molecule RvT4 enhances the body’s natural defences against atherosclerosis (hardening of the arteries) in patients with rheumatoid arthritis.
Queen Mary researchers win PPEF Silver Jubilee Award to investigate best physiotherapy practice for common musculoskeletal conditions 24 January 2024
Researchers from the Centre for Sports and Exercise Medicine at Queen Mary University of London, have been awarded a £500,000 grant from the Private Physiotherapy Educational Foundation (PPEF) for an innovative 3-year research programme. The project aims to integrate research, education, and innovation to define and disseminate best practice for common musculoskeletal conditions.